Robert Weinstein
Chief Financial Officer at TAO Synergies Inc. (TAOX) since June 2021
Robert Weinstein has filed 29 insider reports with the SEC since June 2021, as chief Financial Officer at TAO Synergies Inc. (TAOX), director at XWELL, Inc. (XWEL) and director at PharmaCyte Biotech, Inc. (PMCB) and at 2 more companies. Robert Weinstein made no open-market purchases or sales in the last 12 months. The latest filing, on November 18, 2026, reports grant or award at TAO Synergies Inc. (TAOX).
- Filings
- 29
- Companies
- 5
- Bought on market
- $12.4K
- Sold on market
- $240K
Companies where Robert Weinstein is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Financial Officersince June 2021 | 16,574 | $31.6K | $1.73 | Nov 18, 2026 | |||
| Director | 265,231 | $12.4K | $208K | $0.25 | $0.4655+86% | Sep 3, 2026 | |
| Directorsince November 2022 | 41,250 | $5.37 | Jul 17, 2026 | ||||
| Chief Accounting Officersince June 2026 | 636,004 | Jun 25, 2026 | |||||
| Directorsince May 2023 | $1.16 | Jun 1, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Nov 13, 2026TAOXChief Financial Officer Robert Weinstein was granted 50,000 stock optionsForm 4Grant or award
- Aug 25, 2026XWELDirector Weinstein Robert was granted 50,000 shares, increasing direct ownership by 23% to 265,231 unitsForm 4Grant or award
- Mar 31, 2026PMCBAmendment: SEC Form 4 filed by Director Weinstein RobertForm 4Other acquisition or disposition
- Jun 18, 2026PTPINew insider Weinstein Robert claimed ownership of 636,004 sharesForm 3New insider
- May 18, 2026TAOXSEC Form 4 filed by Chief Financial Officer Weinstein RobertForm 4Grant or award
- Mar 31, 2026PMCBSEC Form 4 filed by Weinstein RobertForm 4Grant or award
- Feb 27, 2026XWELDirector Weinstein Robert was granted 100,000 shares, increasing direct ownership by 87% to 215,231 unitsForm 4Grant or award
- Dec 12, 2025PMCBDirector Weinstein Robert was granted 75,000 shares and covered exercise/tax liability with 33,750 sharesForm 4Grant or awardShares withheld for taxes or exercise price
- Oct 17, 2025TAOXChief Financial Officer Weinstein Robert covered exercise/tax liability with 4,000 shares and was granted 10,000 shares, increasing direct ownership by 57% to 16,574 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Jun 30, 2025TAOXChief Financial Officer Weinstein Robert was granted 15,410 shares and covered exercise/tax liability with 6,164 shares, increasing direct ownership by 696% to 10,574 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Jun 2, 2025XWELDirector Weinstein Robert was granted 107,407 shares, increasing direct ownership by 1,373% to 115,231 unitsForm 4Grant or award
- Nov 15, 2024XWELSEC Form 4 filed by Director Weinstein RobertForm 4Grant or award
- Apr 30, 2024PMCBSEC Form 4 filed by Director Weinstein RobertForm 4Grant or award
- Nov 20, 2023PMCBSEC Form 4 filed by Weinstein RobertForm 4Grant or award
- May 29, 2023TWAVRobert Weinstein became an insiderForm 3New insider
- May 30, 2023+$6,175XWELSEC Form 4 filed by Weinstein RobertForm 4Open-market purchase
- May 26, 2023+$6,250XWELSEC Form 4 filed by Weinstein RobertForm 4Open-market purchase
- Jan 5, 2023XWELSEC Form 4 filed by Weinstein Robert (Amendment)Form 4Grant or award
- Jan 5, 2023XWELSEC Form 4 filed by Weinstein RobertForm 4Grant or award
- Dec 16, 2022-$31.6KTAOXSEC Form 4: Weinstein Robert sold $31,641 worth of shares (27,000 units at $1.17) as part of a pre-agreed trading plan, decreasing direct ownership by 45% to 33,198 units to cover taxesForm 4Open-market sale10b5-1 plan
- Nov 15, 2022TAOXSEC Form 4 filed by Weinstein Robert (Amendment)Form 4Grant or award
- Nov 15, 2022TAOXSEC Form 4 filed by Weinstein RobertForm 4Grant or award
- Nov 14, 2022PMCBRobert Weinstein became an insiderForm 3New insider
- Apr 20, 2022-$47.7KXWELSEC Form 4: Weinstein Robert sold $47,700 worth of shares (45,000 units at $1.06) as part of a pre-agreed trading plan, decreasing direct ownership by 30% to 106,485 unitsForm 4Open-market sale10b5-1 plan
- Jan 26, 2022XWELSEC Form 4: Weinstein Robert was granted 31,250 shares, increasing direct ownership by 19% to 196,485 unitsForm 4Grant or award
- Jan 19, 2022-$70.2KXWELSEC Form 4: Weinstein Robert sold $70,236 worth of shares (45,000 units at $1.56) as part of a pre-agreed trading plan, decreasing direct ownership by 27% to 120,235 unitsForm 4Open-market sale10b5-1 plan
- Sep 20, 2021-$90.2KXWELSEC Form 4: Weinstein Robert sold $90,210 worth of shares (63,000 units at $1.43) as part of a pre-agreed trading plan, decreasing direct ownership by 28% to 165,235 unitsForm 4Open-market sale10b5-1 plan
- Jul 29, 2021XWELSEC Form 4: WEINSTEIN ROBERT was granted 200,000 units of Common Stock, increasing direct ownership by 708% to 228,235 unitsForm 4Grant or award
- Jun 4, 2021TAOXSEC Form 3: WEINSTEIN ROBERT claimed ownership of 198 units of Common StockForm 3New insider
Also sits on boards with
Officers and directors who share two or more companies with Robert Weinstein.
- Joshua Silverman3 shared: TAOX, PTPI, PMCB
- Bruce Bernstein3 shared: TAOX, XWEL, PTPI
- Jonathan Schechter3 shared: PMCB, TWAV, TAOX
- Wayne Remell Walker2 shared: PMCB, PTPI
Compare Robert Weinstein with
- Robert Weinstein vs Joshua Silverman3 shared
- Robert Weinstein vs Bruce Bernstein3 shared
- Robert Weinstein vs Jonathan Schechter3 shared
- Robert Weinstein vs Wayne Remell Walker2 shared
- Robert Weinstein vs William S. Singer1 shared
- Robert Weinstein vs Robert Ephron1 shared
Other insiders at the same companies
- William S. SingerTAOX
- Robert EphronTAOX
- Gerard ReidXWEL
- Gaelle Sandra WizenbergXWEL
- Michael LebowitzXWEL
- Michael M AbecassisPMCB
- Fady BoctorPTPI
- Ezra ErnstXWEL
- Alan J TuchmanTAOX
- Peter HolstTWAV
- Jason T AdelmanTWAV
- Mitchell ArnoldPTPI
Questions about Robert Weinstein
- What is Robert Weinstein's role at TAO Synergies Inc.?
- Robert Weinstein reports to the SEC as chief Financial Officer at TAO Synergies Inc. (TAOX), according to the latest filing on November 18, 2026. Robert Weinstein has also filed as director at XWELL, Inc. (XWEL), director at PharmaCyte Biotech, Inc. (PMCB), chief Accounting Officer at Petros Pharmaceuticals, Inc. (PTPI) and director at Oblong, Inc. (TWAV).
- How many shares does Robert Weinstein own?
- After the latest filing that states it, Robert Weinstein directly owned 16,574 shares of TAO Synergies Inc. (TAOX), 265,231 shares of XWELL, Inc. (XWEL), 41,250 shares of PharmaCyte Biotech, Inc. (PMCB) and 636,004 shares of Petros Pharmaceuticals, Inc. (PTPI). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Robert Weinstein bought or sold stock recently?
- The most recent open-market purchase was on May 30, 2023: bought 25,000 shares of XWELL, Inc. (XWEL) for $6,175 at an average of $0.25. The most recent open-market sale was on December 16, 2022: sold 27,000 shares of Synaptogenix, Inc. (TAOX) for $31.6K at an average of $1.17.
- How do I get alerts when Robert Weinstein files?
- Follow Robert Weinstein on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Robert Weinstein filed 2 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Robert Weinstein (SEC CIK 0001213709). Totals count each trade once, skipping amendments whose original is on file, from Jun 15, 2021 on. View on SEC EDGAR